Pharmaceuticals Insights

4 strategies to help your facility respond to the changing animal health market

The animal health market is changing. These four strategies will help your facility change with it.

Behind every rapid response is a strong regulatory strategy

During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.

Oral solid dosage manufacturing

Oral solid dosage products can take several different shapes, and with those different forms comes different production techniques and facility designs. Here’s what is involved with manufacturing an orally-ingested drug product.

The basics and the process of drug approval

The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?

Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies

Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.

Developing new tools in the pandemic response toolbox

There’s a lot to be learned from the COVID-19 pandemic, including how we can be better prepared for future pandemics.

How long will it take to get a COVID-19 vaccine to market?

Vaccines and therapies can’t come soon enough for a world facing an unprecedented threat from COVID-19.

A COVID-19 roadmap for oral solid dosage manufacturers

OSD products show great promise as treatments for the symptoms of COVID-19.

COVID-19 drug development strategies

All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.